BIOMAT Database Logo BIOMAT Database Logo

Differential stimulation of uterine cells by nafoxidine and clomiphene: relationship between nuclear estrogen receptors and type II estrogen binding sites and cellular growth. 1981

B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009256 Nafoxidine An estrogen antagonist that has been used in the treatment of breast cancer. Nafoxidine Hydrochloride,U-11,100A,U-11000A,Hydrochloride, Nafoxidine,U 11,100A,U 11000A,U11,100A,U11000A
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002996 Clomiphene A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue. Note that ENCLOMIPHENE and ZUCLOMIPHENE are the (E) and (Z) isomers of Clomiphene respectively. Chloramiphene,Clomifene,Clomid,Clomide,Clomifen,Clomiphene Citrate,Clomiphene Hydrochloride,Clostilbegit,Dyneric,Gravosan,Klostilbegit,Serophene,Citrate, Clomiphene,Hydrochloride, Clomiphene

Related Publications

B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
Identification of uterine nuclear type II estrogen binding sites in estrogen treated rats.
July 1986, Journal of steroid biochemistry,
B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
Eosinophils as the source of uterine nuclear type II estrogen binding sites.
March 1984, The Journal of biological chemistry,
B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
RNA polymerase activity and uterine growth: Differential stimulation by estradiol, estriol, and nafoxidine.
April 1976, Biochemistry,
B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
Differential blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
September 1983, Journal of steroid biochemistry,
B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
Relationship between type I and type II estrogen binding sites in the rat uterus.
January 1985, Acta physiologica et pharmacologica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y de la Asociacion Latinoamericana de Farmacologia,
B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
Estradiol-stimulated increases in uterine eosinophils and nuclear type II estrogen-binding sites are prevented by pertussis toxin.
November 1989, Endocrinology,
B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
Uterine type II estrogen-binding sites are not of eosinophil origin.
January 1986, The Journal of biological chemistry,
B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS).
September 1995, Cancer letters,
B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei.
January 1975, Endocrinology,
B M Markaverich, and S Upchurch, and S A McCormack, and S R Glasser, and J H Clark
Relationship between estrogen receptors and cellular proliferation.
January 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
Copied contents to your clipboard!